Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Enhabit, Inc. logo
EHAB

Enhabit, Inc.

MaveScore 31 Low model confidence
Last Price US$13.80 As of May 14, 2026
DCF Fair Price US$21.42 Research estimate · Jul 10, 2026 +55.2% vs price
Market Cap US$706.6m Company size context
7D Performance 0.22% Past 7 days
1Y Performance 30.43% Past 12 months
Model Rating
Historical model output for research review

Fundamental data date

Mar 31, 2026

102 days old

Market price date

May 14, 2026

58 days old

Coverage

16/16

No missing model inputs

Data quality

Review

Partial or delayed snapshot

Transparent research score

Why the model scores this stock

MaveScore is a research prioritization score from 0 to 100. It is historical model output for watchlist review, not personalized financial advice.

MaveScore 31 Low confidence

Stored data quality

Freshness and coverage checks

16/16 Partial or delayed snapshot

Quality

7/35 Weak

Blends latest model rank with profitability and dilution ranks.

Financial Strength

7/25 Weak

Rewards durable profitability, margins, and positive free cash flow.

Valuation Support

5/15 Weak

Favors positive earnings, positive cash flow, and lower multiples.

Momentum

11/15 Strong

Highlights research candidates with supportive 3-month and 6-month price regimes.

Shareholder Alignment

1/10 Weak

Rewards less dilutive share behavior and enough size for liquid research coverage.

Positive model output

  • Highlights research candidates with supportive 3-month and 6-month price regimes.

Research risks to review

  • Blends latest model rank with profitability and dilution ranks.
  • Rewards durable profitability, margins, and positive free cash flow.
  • Favors positive earnings, positive cash flow, and lower multiples.

MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting.

Dashboard Funda..tals Prediction Screener Map

Enhabit, Inc. Overview

Industry: Medical Care Facilities

Sector: Healthcare

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is based in Dallas, Texas. Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services Read More

Enhabit, Inc. is evaluated based on the investment philosophy and approach to stock market investing developed by renowned investor Warren Buffett. Companies with high ratings typically exhibit growing earnings, a substantial profit margin, conservative leverage, a consistently high return on equity, and a sustained practice of repurchasing their shares over the years.

Enhabit, Inc.

Score

Reported Results

No latest earnings report cached yet

Run the EDGAR earnings refresh to load the latest company-filed earnings release, 10-Q, 10-K, or transcript exhibit for this ticker.

Recent News



Earnings Per Share

Score 1.00/5
Enhabit, Inc. earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
In Medical Care Facilities industry , Universal Health Services Inc , DaVita HealthCare Partners Inc , CHEMED CORP are companies with high ratings.

Return on Equity

Score 1.17/5
Enhabit, Inc. exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
Enhabit, Inc... EHAB US$706.6m
Zoetis Inc ZTS US$31.4b
IQVIA Holdin... IQV US$34.6b
Agilent Tech... A US$36.9b

Net Margin

Score 1.30/5
Enhabit, Inc. olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
Enhabit, Inc... EHAB US$706.6m
Zoetis Inc ZTS US$31.4b
IQVIA Holdin... IQV US$34.6b
Agilent Tech... A US$36.9b

Share Buyback

In Medical Care Facilities industry , Universal Health Services Inc , DaVita HealthCare Partners Inc , CHEMED CORP are companies with high ratings.

Leverage

Score 1.95/5
Enhabit, Inc. registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc have achieved high scores.
Enhabit, Inc... EHAB US$706.6m
Zoetis Inc ZTS US$31.4b
IQVIA Holdin... IQV US$34.6b
Agilent Tech... A US$36.9b

Financial Statements

Company-reported SEC EDGAR facts organized into the three core statements.

SEC financial statements are temporarily unavailable.

Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

Financial Ratio

Yearly Quarterly

Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios

Enhabit, Inc. logo

Enhabit, Inc.

US$13.80

US$21.42

+55.2% vs price

US$706.6m

0.22%

30.43%